药品零售高质量发展政策出台，利好头部零售药店

Investment Rating - The industry investment rating is "Leading the Market" [2][5]. Core Viewpoints - The report emphasizes that the pharmaceutical retail industry is entering a phase of high-quality development, supported by government policies aimed at promoting the sector [5]. - Key initiatives include accelerating the outflow of prescriptions, enhancing industry concentration, and fostering innovation in health services, which are expected to benefit leading retail pharmacies [5]. - The report suggests that leading retail pharmacies are well-positioned to capitalize on these trends due to their strong compliance, refined management capabilities, and financial health [6]. Summary by Relevant Sections Industry Overview - The pharmaceutical retail sector is recognized as a crucial part of the national healthcare system, with a focus on enhancing professional services and emergency supply capabilities [5]. - The report outlines 18 development measures across five areas: improving pharmaceutical services, innovating health services, strengthening emergency services, optimizing industry structure, and regulating industry order [5]. Market Dynamics - The report indicates that the outflow of hospital prescriptions will contribute to growth in the pharmaceutical retail sector, with measures to enhance the efficiency of electronic prescription platforms [5]. - It highlights the encouragement of horizontal mergers and acquisitions among retail pharmacies to increase industry concentration and streamline operations [5]. Future Outlook - The report anticipates that with ongoing consumer promotion policies and a gradual reduction in regulatory impacts, leading retail pharmacies will see improved operational performance [6]. - It recommends focusing on leading retail pharmacies with strong management capabilities, compliance, and advantageous locations, such as Yifeng Pharmacy [6].